Ling Fang

Ling Fang is an experienced professional in overseas investment and management, currently serving as the Overseas Post-Investment Management at Shanghai Pharmaceuticals Holding Co., Ltd. since January 2019. Previously, Ling held key positions in strategy and M&A at Master Kong Holdings Co. Ltd. and managed overseas investment at Bright Food Group. Ling's expertise encompasses overseas strategic planning, investment opportunity assessment, deal execution, and post-transaction management, including portfolio monitoring and risk analysis. Additionally, Ling has a background in project management in M&A and pre-IPO projects, beginning a career in corporate banking at Commerzbank AG. Academic qualifications include a Master of Science in Insurance and Risk Management from Cass Business School, City University of London, and a Bachelor of Arts (Hons) in Business Management from Kingston University.